Portfolio company
Animab
Belgium
Raised
Undisclosed
Latest stage
Series A
Rounds recorded
1 · 1 undisclosed
Backed by
7 investors
Sectors
About
Animab develops oral monoclonal antibody products for livestock farmers to control gastrointestinal pathogens and improve animal health without using antibiotics.
SourceFunding history · 1
Similar companies
PhageLab
PhageLab develops bacteriophage treatments to control bacterial pathogens in livestock and poultry production, reducing the industry's reliance on antibiotics.
Resilient Biotics
This company develops microbiome-derived live biotherapeutics to prevent and treat respiratory diseases in livestock and humans.
ArkVax
ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.
Aviwell
This company develops microbiota-based feed solutions using an AI discovery platform to improve livestock growth and health for the agri-food industry.
Phagos
The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.
BiomEdit
BiomEdit develops microbiome-derived probiotics and microbial medicines to improve the health and productivity of livestock and pets for the animal health industry.
PetMedix
PetMedix develops species-specific monoclonal antibody therapeutics for companion animals to treat chronic and terminal diseases in dogs and cats.
Advanced Animal Diagnostics
This company develops on-farm diagnostic tests for livestock producers to detect infections and manage animal health.
